Institutional members access full text with Ovid®

Share this article on:

Enterobacteriaceae Infections of Very Low Birth Weight Infants in Polish Neonatal Intensive Care Units: Resistance and Cross-transmission

Wójkowska-Mach, Jadwiga MS, PhD*; Chmielarczyk, Agnieszka MS, PhD*; Borszewska-Kornacka, Maria MD, PhD; Domańska, Joanna MS, PhD; Gadzinowski, Janusz MD, PhD§; Gulczyńska, Ewa MD, PhD; Nowiczewski, Marek MD, PhD; Helwich, Ewa MD, PhD; Kordek, Agnieszka MD, PhD**; Pawlik, Dorota MD, PhD††; Jursa-Kulesza, Joanna MD, PhD‡‡; Giedrys-Kalemba, Stefania MD, PhD‡‡; Szczapa, Jerzy MD, PhD§; Heczko, Piotr B. MD, PhD*

The Pediatric Infectious Disease Journal: June 2013 - Volume 32 - Issue 6 - p 594–598
doi: 10.1097/INF.0b013e318287fe2a
Original Studies

Background: The aims of our study were analysis of the occurrence of infections by members of the Enterobacteriaceae family in 6 Polish neonatal intensive care units in 2009, their drug resistance, the epidemiology of extended-spectrum β-lactamase (ESBL)-producing strains and the possibility of using modern tools of microbiology diagnosis in infection control, especially for the reduction of antimicrobial resistance.

Methods: A prospective surveillance covered 910 newborns. Case patients were defined as neonates with very low birth weight who had clinical signs of septicemia, pneumonia or necrotizing enterocolitis. Early-onset infection was defined as infection diagnosed within 3 days after delivery.

Results: The incidence of Enterobacteriaceae infections was 2.6/1000 patient-days. The risk of Enterobacteriaceae pneumonia increased with the length of hospitalization (P = 0.0356). The most common pathogen was Escherichia coli (12.4% of all strains, in early-onset infection 18.5%) and Klebsiella spp. (9.1% of all). The ESBL phenotype was found in 37% of isolates, of which 89.3% were producing CTX-M-type, 70.2% TEM-type and 8.5% SHV-type. Epidemic clones were detected in the 2 studied neonatal intensive care units: 6 of the 9 ESBL-positive Enterobacter cloacae and 16 of the 18 ESBL-positive Klebsiella pneumoniae strains were classified into 1 epidemic clone, which showed resistance to penicillin without inhibitors, amoxycillin/clavulanic acid, cephalosporins, aztreoname, aminoglycosides and trimethoprim/sulfamethoxazole.

Conclusions: Enterobacteriaceae bacilli are a significant problem in neonatal intensive care units, especially in early-onset infection and for long hospitalized very low birth weight infants. The observed high drug resistance was in large part related to the dominance of epidemic strains as a result of horizontal transmission. The best way to reduce drug resistance would be adequate procedures of isolation and hand hygiene.

From the *Microbiology, Jagiellonian University Medical College, Krakow; Clinic of Neonatology and Intensive Neonatal Care, Warsaw Medical University, Warsaw; Institute of Theoretical and Applied Informatics of the Polish Academy of Sciences, Gliwice; §Department of Neonatology, Poznan University of Medical School, Poznan; Clinic of Neonatology, Polish Mother’s Memorial Hospital-Research Institute, Lodz; Clinic of Neonatology and Intensive Neonatal Care, Institute of Mother and Child, Warsaw; **Department of Neonatal Diseases, Pomeranian Medical University, Szczecin; ††Clinic of Neonatology, Jagiellonian University Medical College, Krakow; and ‡‡Department of Microbiology and Immunology, Pomeranian Medical University, Szczecin, Poland.

Accepted for publication January 15, 2013.

This study was partially supported by a grant from the Ministry of Science and Higher Education (DEC-2011/01/D/N27/00104). The authors have no other funding or conflicts of interest to disclose.

Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal’s website (www.pidj.com).

Address for correspondence: Jadwiga Wójkowska-Mach, MS, PhD, Chair of Microbiology, Jagiellonian University Medical College, 18 Czysta Street, 31–121 Krakow, Poland. E-mail: mbmach@cyf-kr.edu.pl.

© 2013 Lippincott Williams & Wilkins, Inc.